M2 Macrophage-Derived Exosomal miR-31-5p Facilitates Oral Squamous Cell Carcinoma Tumourigenesis
Yi Yuan,Mengqi Chen,Yang Jing,Zeyu Wang,Wei Shu,Zhuoying Xie,Youjin Dai,Zhiyang Li,Juanyong Xu,Feng He,Pengfei Jiao,Jiaqing Wang,Jiamin Xu,Yan Xia,Siyu Liu,Hongming Du,Lu Dai,Yaqin Zhang,Hongwei Li
DOI: https://doi.org/10.2139/ssrn.3670908
2020-01-01
SSRN Electronic Journal
Abstract:Clinical and investigational proof indicates that tumour-related macrophages stimulate tumour initiation and development. Consequently, macrophage-derived molecular factors controlling OSCC initiation are not yet completely understood. Here, we show that M2 macrophage–regulated OSCC cell growth and tumorigenicity depend on M2 macrophage-derived exosomes (M2 exo). M2 exo exhibited a high level of miR-31-5p, and the M2 exo-mediated increase in OSCC cell proliferation and growth depended on this miRNA. Mechanistically, miR-31-5p was delivered to OSCC cells through M2 exo and complementary pairing with the LATS2 coding sequence, thus suppressing the expression of LATS2, which has been considered to be a major aspect inhibiting OSCC growth. Collectively, our findings demonstrate that M2 exo participate in OSCC tumorigenesis, and M2 exo mediate their tumour-inducing effect via the miR-31-5p/LATS2 axis of the Hippo signalling pathway in OSCC. This active and mutual communication among OSCC cells and M2 macrophages provides a novel strategy for treating OSCC.Funding Statement: This work was supported by research grants from the National Natural ScienceFoundation of China (21872026), the Outstanding Young scholar Foundation of Jiangsu Province, China (BK20170106), the Major Projects of Science and Technology Development Fund of Nanjing Medical University (NMUD2019001), the Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nan-jing University, China (KF-GN-201903), the Southeast University and Nanjing Medical University Cooperative Research Project, China (2019DN0003), the Open Research Fund of State Key Laboratory of Bioelectronics, Southeast University. Declaration of Interests: None.Ethics Approval Statement: The study procedure was under the approval of the Ethics Committee of Stomatology Hospital Affiliated to Nanjing Medical University, and written informed consent was obtained from every patient.